XML 30 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segment Information (Tables)
 9 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Information concerning unaudited combined operations by business segment
Information concerning unaudited combined operations by business segment is presented in the following table:
 
Three Months Ended
September 30
 
 
 
Nine Months Ended
September 30
 
 
 
2014
 
2013
 
Change
 
2014
 
2013
 
Change
NET SALES
 
 
 
 
 
 
 
 
 
 
 
Surgical and Infection Prevention
$
279.2

 
$
287.0

 
-2.7
 %
 
$
840.2

 
$
860.1

 
-2.3
 %
Medical Devices
122.5

 
126.2

 
-2.9
 %
 
373.5

 
366.8

 
1.8
 %
Corporate & Other
6.8

 
6.3

 
7.9
 %
 
19.0

 
19.3

 
-1.6
 %
COMBINED TOTAL NET SALES
$
408.5

 
$
419.5

 
-2.6
 %
 
$
1,232.7

 
$
1,246.2

 
-1.1
 %
 
 
 
 
 
 
 
 
 
 
 
 
OPERATING PROFIT
 
 
 
 
 
 
 
 
 
 
 
Surgical and Infection Prevention
$
36.8

 
$
45.2

 
-18.6
 %
 
$
118.1

 
$
113.0

 
4.5
 %
Medical Devices
20.4

 
28.0

 
-27.1
 %
 
76.6

 
63.4

 
20.8
 %
Corporate & Other(a)
(44.8
)
 
(3.1
)
 
N.M.

 
(126.8
)
 
(10.6
)
 
N.M.

Other (income) and expense, net
(0.7
)
 
(0.2
)
 
N.M.

 
(2.4
)
 
(1.9
)
 
N.M.

COMBINED TOTAL OPERATING PROFIT
$
13.1

 
$
70.3

 
-81.4
 %
 
$
70.3

 
$
167.7

 
-58.1
 %
N.M. - Not Meaningful
(a)
Corporate & Other for the three and nine months ended September 30, 2014 includes $6 and $55, respectively, associated with Manufacturing Footprint Strategic Changes related to the S&IP business (see Note 3) and $35 and $61, respectively, of transaction costs associated with the Spin-off.